Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences, Beijing Chaoyang Hospital and the University of Queensland have developed a new formulation based on regulatory T-cell exosomes (rEXS) to deliver vascular endothelial growth factor (VEGF) antibodies for choroidal neovascularization therapy.
Exosome formulation developed to deliver antibodies for choroidal neovascularization therapy
- EurekAlert
- 26. 7 2021 (06:00)